Impact of the Purdue Pharma Settlement
After more than 6 years, the criminal case involving the opioid crisis and Purdue Pharma is coming to a close. The nearly $7.4 billion Purdue Pharma settlement payout is now legally effective after almost a decade of work from attorneys general across the country. The Purdue Pharma settlement represents more than just a financial transaction. It has set a precedent for a profound attempt to hold corporate entities accountable, while providing overdue support for recovery and public health.
The opioid drug epidemic has affected millions of families across the US for decades. It devastated communities and fundamentally altered the healthcare landscape. The very center of this public health crisis was the manufacturer of OxyContin. The Stamford, Connecticut-based company, Purdue Pharma’s criminal case has been one of the most complex cases.
The company previously pleaded guilty to misbranding and fraud related to its marketing of OxyContin in 2007. The company admitted to falsely advertising the drug as less addictive and less likely to cause withdrawal symptoms compared to other rival pain medications. Purdue admitted to paying doctors through speaker programs to fuel drug sales, to encouraging more opioid prescriptions and to deceiving federal regulators about efforts to prevent illegal drug use.
Ultimately, US officials say Purdue Pharma’s actions directly contributed to the spread of opioid addiction and overdose. It left the country vulnerable to the fentanyl crisis, which continues to kill thousands of people every year.
The Root Cause
According to federal data, more than 900,000 deaths in the US are connected to the opioid drug crisis since 1999. It was first driven by prescription opioids like OxyContin. It then moved to street opioids like heroin. And today, semi-synthetic opioids like fentanyl have taken over the drug overdose public health crisis.
In June 2018, the state of Massachusetts filed the first lawsuit by any state against the members of the Sackler family and other executives of Purdue Pharma. However, when the company filed for bankruptcy in 2019, it only delayed any settlements and further charges to the company.
The lawsuit timeline actually stretches back to the late 1990s and early 2000s, when the drug was aggressively marketed to doctors as a safe and highly effective pain medication. Addiction rates soon skyrocketed. This set the way for legal pushback.
Victims and municipalities began filing separate lawsuits. But as the sheer volume of claims grew, it led to a multidistrict litigation where thousands of claims would be consolidated into a more streamlined process. The immense pressure on the drug manufacturer from the lawsuits threatened to bankrupt the company. It faced billions of dollars in liabilities from states, cities, hospitals and individuals.
The Purdue Pharma Settlement
According to analysis by Opioid Settlement Tracker, the estimated value of all opioid lawsuits settlements since 2019 is close to %57.8 billion. The current settlement provides a $7.4 billion payout with about $6.5 billion to come from members of the Sackler family, who owned Purdue Pharma. The settlement will provide funds to communities across the country as well as individual victims and other groups who filed claims.
55 attorneys general representing all eligible US states and territories signed onto the settlement. This ultimately resolves the litigation against Purdue and the Sacklers for their part in producing and aggressively marketing addictive opioids, which drove the largest drug crisis in US history.
Most of the funds from the settlement will go to government entities used to fight the opioid crisis. Purdue Pharma and the Sacklers will be allowed to pay over the course of 15 years. The Sacklers are paying about $1.5 billion today. An additional $500 million will be paid in May 2017. Another $500 million will be paid in May 2028. And about $400 million will be paid in May 2029.
What does this Purdue Pharma Settlement mean for Victims: Compensation and Claims
For those who were directly impacted by the crisis, understanding the legal proceedings can be frustrating. The settlement is designed to distribute funds to a wide variety of claimants, which include local governments, Native American tribes, hospitals, and individuals. For individual claims, payouts can range from a few thousand dollars to about $48,000, depending on the severity of harm suffered.
Eligibility requirements are needed in order to see part of the payout settlement.
- Proof that the individual was prescribed OxyContin or another relevant Purdue Pharma-manufactured opioid drug.
- Documented evidence of harm, such as medical records proving addiction, overdose or prolonged hospitalization.
- Death certificate linking cause of death to opioid use.
Some victims of the opioid crisis expressed frustration with the lengthy duration of the settlement. The company’s filing for bankruptcy in 2019 only delayed any settlement claims. In addition, some have been unable to find old prescription records required to qualify for the payout.
Check Your Insurance Coverage for FREE
Find out if your insurance covers addiction treatment in minutes. We accept most insurance!
Systemic Impact of the Purdue Pharma Settlement
The vast majority of the settlement will be put toward systemic public health changes. Historically, funds from massive corporate settlements have been diverted to fill budget gaps like fixing roads or funding unrelated projects. But with this settlement, the state attorneys general have drafted strict spending parameters.
- Expansion of treatment centers. Building and staffing accessible inpatient and outpatient substance use disorder facilities, especially in rural and underserved areas.
- Overdose reversal medications. Subsidizing a widespread distribution of naloxone to first responders, schools and accessibility to the general public.
- MAT. Makes evidence-proven medications such as methadone and buprenorphine more affordable and accessible to low-income individuals.
- Prevention and education. Fund community outreach programs that educate youth about the dangers of prescription drug use.
Corporate Restructuring
Under the terms of the settlement deal, the Sacklers are barred from selling opioids in the US. The company will be dissolved and replaced by Knoa Pharma, a company focused on public good with a mission to fight the opioid epidemic. This new entity is legally bound to funnel its future profits directly to the Purdue Pharma settlement fund.
In addition, the Sackler family agreed to contribute about $6 billion of their own personal wealth to the settlement fund. But it came with a controversial caveat.
What about the Sackler Family?
Under the deal, members of the Sackler family would be shielded from lawsuits over opioids from those who agree to the settlement payout. Only the company is being criminally charged. Members of the Sackler family still claim they have done nothing wrong and have not been charged with any crime.
Reach out to Hotel California by the Sea
We specialize in treating addiction and other co-occurring disorders, such as PTSD. Our Admissions specialists are available to walk you through the best options for treating your addiction.
Treatment for Opioid Use Disorder
The Purdue Pharma settlement is an important moment in corporate accountability and public health. While the delay of the settlement payout has frustrated many waiting for financial relief, it is finally being put into motion. The outcome of the settlement sends a message that even bankruptcy courts cannot be used as a loophole for the wealthy to escape civil liability.
Professional behavioral health programs like Hotel California by the Sea provide treatment for those with opioid use disorders. We offer treatment at all levels of care including detox, residential, PHP and IOP. We utilize evidence-based methods such as CBT, DBT and EMDR therapy. Hotel California by the Sea is dedicated to helping clients reach their goals in sobriety and overcome their addiction.
References:
https://www.theguardian.com/society/2026/apr/29/purdue-pharma-dissolved-replaced-opioid-settlement
